S. Schwartz

1.4k total citations
32 papers, 1.0k citations indexed

About

S. Schwartz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, S. Schwartz has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in S. Schwartz's work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmacology and Obesity Treatment (2 papers). S. Schwartz is often cited by papers focused on Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (3 papers) and Pharmacology and Obesity Treatment (2 papers). S. Schwartz collaborates with scholars based in United States, Spain and India. S. Schwartz's co-authors include Lawrence Blonde, Bernard Zinman, John B. Buse, Marija Zdravković, Alex Lewin, Paula M. Hale, Philip Raskin, J. E. Gerich, R Levine and Norman S. Track and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

S. Schwartz

32 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Schwartz United States 14 317 311 229 193 186 32 1.0k
Pawel Namsolleck Germany 20 378 1.2× 653 2.1× 109 0.5× 162 0.8× 67 0.4× 35 1.5k
Enzo Ragazzoni∘ Italy 16 63 0.2× 268 0.9× 87 0.4× 84 0.4× 194 1.0× 44 1.2k
Jun-ichi Yamakawa Japan 19 131 0.4× 255 0.8× 155 0.7× 50 0.3× 48 0.3× 55 1.1k
N Yoshimura United States 17 91 0.3× 206 0.7× 181 0.8× 81 0.4× 98 0.5× 31 1.6k
Kay D. Beharry United States 23 56 0.2× 274 0.9× 241 1.1× 56 0.3× 113 0.6× 111 1.7k
James C. Strand United States 17 121 0.4× 442 1.4× 92 0.4× 77 0.4× 26 0.1× 24 1.3k
Michael J. Theodorakis United States 14 803 2.5× 350 1.1× 494 2.2× 127 0.7× 36 0.2× 27 1.8k
C Weinkove United Kingdom 15 146 0.5× 257 0.8× 172 0.8× 42 0.2× 63 0.3× 35 773
Erzsébet Fehér Hungary 18 69 0.2× 208 0.7× 133 0.6× 267 1.4× 21 0.1× 64 907
Gaëtan Prévost France 18 407 1.3× 158 0.5× 387 1.7× 58 0.3× 22 0.1× 68 1.1k

Countries citing papers authored by S. Schwartz

Since Specialization
Citations

This map shows the geographic impact of S. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Schwartz more than expected).

Fields of papers citing papers by S. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Schwartz. The network helps show where S. Schwartz may publish in the future.

Co-authorship network of co-authors of S. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of S. Schwartz. A scholar is included among the top collaborators of S. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Schwartz. S. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terra, Steven G., Veena Somayaji, S. Schwartz, et al.. (2011). A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 119(7). 401–407. 7 indexed citations
2.
Zinman, Bernard, J. E. Gerich, John B. Buse, et al.. (2010). Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met + TZD) (Diabetes Care (2009) 32, (1224-1230)). Diabetes Care. 33(3). 240 indexed citations
3.
Serra, Denise, Julie Bullock, S. Schwartz, et al.. (2008). Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes. International Journal of Clinical Pharmacology and Therapeutics. 46(7). 349–364. 25 indexed citations
4.
Furtado, Sarah, Cynthia R. Cimino, Sarah Eichler, et al.. (2002). Bilateral human fetal striatal transplantation in Huntington’s disease. Neurology. 58(5). 687–695. 174 indexed citations
5.
Hollander, Priscilla, et al.. (2000). Nateglinide, but not glyburide, selectively enhances early insulin release and more effectively controls post-meal glucose excursions with less total insulin exposure. Diabetes Research and Clinical Practice. 50. 70–71. 7 indexed citations
6.
Andreu, Antoni L., et al.. (1996). Thiolprotease activity in skeletal and myocardial muscle and liver of fasted rats.. PubMed. 11(3). 289–91. 1 indexed citations
7.
8.
Clifton, G. Dennis, et al.. (1994). Pharmacodynamics of Racemic and S(—)‐Atenolol in Humans. The Journal of Clinical Pharmacology. 34(8). 816–822. 9 indexed citations
9.
Yeh, K. C., et al.. (1989). Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.. PubMed. 39(11 Suppl 2). 25–38. 135 indexed citations
10.
Manu, Peter, et al.. (1985). Analysis of publication output of internal medicine faculty members. Academic Medicine. 60(11). 860–4. 6 indexed citations
11.
Manu, Peter & S. Schwartz. (1983). Patterns of diagnostic testing in the academic setting: The influence of medical attendings' subspeciality training. Social Science & Medicine. 17(18). 1339–1342. 18 indexed citations
12.
Schwartz, S., et al.. (1983). Dietary fiber decreases cholesterol and phospholipid synthesis in rat intestine. Journal of Lipid Research. 24(6). 746–752. 23 indexed citations
13.
Manu, Peter, et al.. (1983). Authors Generate Authors. Annals of Internal Medicine. 98(1). 108–108. 1 indexed citations
14.
Gabbe, Steven G., et al.. (1982). Effect of dietary fiber on the oral glucose tolerance test in pregnancy. American Journal of Obstetrics and Gynecology. 143(5). 514–517. 9 indexed citations
15.
Schwartz, S. & John M. Dietschy. (1980). Permeability characteristics of muscle membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 600(3). 961–973. 8 indexed citations
16.
Schwartz, S.. (1978). Normal Jejunal Cyclic Nucleotide Content in a Patient With Secretory Diarrhea. Archives of Internal Medicine. 138(9). 1403–1403. 4 indexed citations
17.
Schwartz, S., et al.. (1977). Hepatoma presenting as lower gastrointestinal bleeding.. PubMed. 67(5). 485–8. 14 indexed citations
18.
Schwartz, S., et al.. (1977). Antral mucosal diaphragm. Gastrointestinal Endoscopy. 24(1). 33–34. 8 indexed citations
19.
Schwartz, S.. (1967). Rheumatoid Carditis. JAMA. 201(7). 556–556. 9 indexed citations
20.
Schwartz, S., et al.. (1966). A survey of vascular diseases of the small intestine. Seminars in Roentgenology. 1(2). 178–218. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pawel Namsolleck Breakdown of academic impact, for papers by Enzo Ragazzoni∘ Breakdown of academic impact, for papers by Jun-ichi Yamakawa Breakdown of academic impact, for papers by N Yoshimura Breakdown of academic impact, for papers by Kay D. Beharry Breakdown of academic impact, for papers by James C. Strand Breakdown of academic impact, for papers by Michael J. Theodorakis Breakdown of academic impact, for papers by C Weinkove Breakdown of academic impact, for papers by Erzsébet Fehér Breakdown of academic impact, for papers by Gaëtan Prévost
Rankless by CCL
2026